Unknown

Dataset Information

0

ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer.

ABSTRACT:

SUBMITTER: Deng J 

PROVIDER: S-EPMC8205437 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1-Mutant Lung Cancer.
| S-EPMC12709056 | biostudies-literature
Unknown Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity.
| S-EPMC5551575 | biostudies-literature
Unknown Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.
| S-EPMC5932405 | biostudies-literature
Transcriptomics Hippo signaling-controlled MHC-I antigen processing and presentation pathway potentiates antitumor immunity
2024-02-01 | GSE253053 | GEO
Unknown Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity.
| S-EPMC9012282 | biostudies-literature
Unknown Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer.
| S-EPMC12265828 | biostudies-literature
Unknown MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma.
| S-EPMC11161201 | biostudies-literature
Unknown A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
| S-EPMC5058719 | biostudies-literature
Unknown Nanoscale coordination polymer synergizes photodynamic therapy and toll-like receptor activation for enhanced antigen presentation and antitumor immunity.
| S-EPMC10841466 | biostudies-literature
Unknown Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.
| S-EPMC6942613 | biostudies-literature